FDA·Medicines·January 28, 2026

Graviti Pharmaceuticals recalls Furosemide 40 mg tablets over foreign substance found in product

The recall covers 4212 bottles of furosemide tablets (40 mg, 1,000 count) because a foreign substance was found in the product, and the notice does not say what the substance is.

What to do

The notice does not give instructions. Read the official notice for details.

Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.

Recall details

Product
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Hazard
Presence of Foreign Substance
Units
4212 bottles
Where sold
U.S. Nationwide
FDA classification
Class II · Ongoing
Classified by FDA
January 21, 2026
Recall started
January 10, 2026
FDA enforcement report
January 28, 2026
Identifiers
  • Codes: Lot# FUB125042G; Exp. 05/13/2027
  • FDA recall number: D-0293-2026

The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.

Official notice

The notice's own wording from FDA.

Product
Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ 08816, Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, India, NDC 64980-563-10.
Reason for recall
Presence of Foreign Substance
Classification
Class II (Ongoing)
Distribution
U.S. Nationwide
Quantity
4212 bottles

Related recalls